Search research articles
Contact Us
Filters
Showing results (351-360 of 480) with videos related to
Page
of 48
Sort By:
Neuroscience and Biobehavioral Reviews
|
February 12, 2023
Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis
Sara Pisani, Brandon Gunasekera, Yining Lu, et al.
Health Technology Assessment (Winchester, England)
|
January 7, 2021
Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies
Kathryn Richardson, George M Savva, Penelope J Boyd, et al.
Frontiers in Neurology
|
September 28, 2020
Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, et al.
Cellular Signalling
|
March 8, 2025
Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment
Christina Elliott, Joshua Jackson, Jane Findlay, et al.
Journal of Alzheimer'S Disease : JAD
|
July 1, 2019
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders
Youssef H El-Hayek, Ryan E Wiley, Charles P Khoury, et al.
International Psychogeriatrics
|
April 14, 2021
Cross-sectional association between objective cognitive performance and perceived age-related gains and losses in cognition
Serena Sabatini, Obioha C Ukoumunne, Clive Ballard, et al.
CNS Drugs
|
July 18, 2016
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study
Janet Sultana, Andrea Fontana, Francesco Giorgianni, et al.
Plos Medicine
|
February 7, 2018
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial
Clive Ballard, Anne Corbett, Martin Orrell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 26, 2016
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Erika Bereczki, Paul T Francis, David Howlett, et al.
International Journal of Geriatric Psychiatry
|
January 27, 2023
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings
Joanne McDermid, Clive Ballard, Zunera Khan, et al.
Page
of 48
Search research articles
Search
Showing results (351-360 of 480) with videos related to
Sort By:
Page
of 48
Neuroscience and Biobehavioral Reviews
|
February 12, 2023
Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis
Sara Pisani, Brandon Gunasekera, Yining Lu, et al.
Health Technology Assessment (Winchester, England)
|
January 7, 2021
Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies
Kathryn Richardson, George M Savva, Penelope J Boyd, et al.
Frontiers in Neurology
|
September 28, 2020
Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, et al.
Cellular Signalling
|
March 8, 2025
Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment
Christina Elliott, Joshua Jackson, Jane Findlay, et al.
Journal of Alzheimer'S Disease : JAD
|
July 1, 2019
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders
Youssef H El-Hayek, Ryan E Wiley, Charles P Khoury, et al.
International Psychogeriatrics
|
April 14, 2021
Cross-sectional association between objective cognitive performance and perceived age-related gains and losses in cognition
Serena Sabatini, Obioha C Ukoumunne, Clive Ballard, et al.
CNS Drugs
|
July 18, 2016
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study
Janet Sultana, Andrea Fontana, Francesco Giorgianni, et al.
Plos Medicine
|
February 7, 2018
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial
Clive Ballard, Anne Corbett, Martin Orrell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 26, 2016
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Erika Bereczki, Paul T Francis, David Howlett, et al.
International Journal of Geriatric Psychiatry
|
January 27, 2023
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings
Joanne McDermid, Clive Ballard, Zunera Khan, et al.
Page
of 48